Endexx Corporation Officially Changes Name to CBD Unlimited, Inc.
Company to Submit FINRA Application for Corporate Name and Symbol Change
|
|||||
CAVE CREEK, AZ, Nov. 19, 2018 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – Endexx Corporation (OTC PINK: EDXC), announced today that it has received approval from the Nevada Corporation Commission, completing its requested name change from Endexx Corporation to CBD Unlimited, Inc. The company will now seek approval from FINRA for a corporate name change to CBD Unlimited, Inc. and a new stock symbol.
“Since 2014 we have been building our brand as one of the pioneering companies under the U.S. Farm Bill Act of 2014’s pilot program for hemp,” said Chief Executive Officer Todd Davis. “During this time, CBD Unlimited has quickly developed into a trusted brand within the hemp industry. Anticipating the Farm Bill Act of 2018, we are confident ‘The New Hemp Law’ will be conducive to the official launch of the hemp industry in the United States. The name CBD Unlimited, Inc. best reflects our company’s position and strength on behalf of the shareholders.”
CBD Unlimited’s leading product suite include Maggie’s Balm, Maggie’s Mist, Mad Hatter CBD Chai Tea, Amrita, Nightcaps, Tidal Cloud, and Controlled Dose Oils and Capsules. It’s best-selling product Phyto-Bites®, a cannabidiol (CBD) infused treats for dogs that treat common physical ailments and separation anxiety, along with additional developing hemp-derived product lines have solidified CBD Unlimited’s market position. Adopting the brand name provides the company a logical transition to its trusted quality and expertise, and helps create increased relevancy to investors and shareholders.
The company fully complied with the four year “Pilot Program Provision” initiated in 2014 under the US Farm Bill Act of 2014. In the beginning, the company conducted four case studies in the clinical environment enlisting four physicians, two veteran pharmacists, and nearly 200 volunteer patients with diabetic neuropathy who eagerly tested CBD as a supportive therapy for their advanced chronic conditions. Each delivery platform was tested for four weeks. The delivery methods include vape delivery from an electronic cigarette, sublingual oral oil formulations, and two different capsule delivery methods. Two key measurements were reported on by the patients, sleep quality and pain reduction based on a (NRS)Numerical rating scale using numbers from 1-10 with 10 being maximum pain. The pilot program allowed our physicians to establish and identify baseline dosing parameters per delivery method. These parameters were then utilized to create formulations that consumers could rely on to achieve high therapeutic value and noticeable beneficial bio feedback experiences.
“We are set to file our application with FINRA for a new symbol change reflecting CBD Unlimited, Inc.,” said Mr. Davis. “It is an exciting time for CBD Unlimited and we remain committed to growing our brand and positioning the Company for future growth opportunities.”
About CBD Unlimited, Inc.
CBD Unlimited, Inc., with its collaborative partners and consultants, develops and distributes two consumable product lines derived from Hemp, which is all-natural and rich in phyto-cannabinoids. Phyto-Bites® is its CBD-infused soft chews for dogs. The dog treats are formulated to promote health and support the reduction of separation anxiety, pain and inflammation.
The company also has two key technology products and services that launched in 2014. Both products provide essential solutions to promote regulatory compliance and full accountability through asset protection, inventory management, compliance and an “end of sale” technology integration. Based on principles developed by the pharmacological industry, the integrated “Gorilla-Tek” platform is the first standardized hardware agnostic and software solution for tracking high- risk high-shrink regulated and restricted products that maintains compliance with federal, state and local regulations. It is intended to provide conformity with federal and state mandates. Gorilla-Tek™ is also a commercial-grade inventory control and dispensing device that provides up-to-the-minute accounting details and ensures both product and patient security. By automating the dispensing process, Gorilla-Tek™ increases productivity and reduces costs for retailers, while enhancing their service quality by reducing transaction time for customers.
Websites include: www.cbdunlimited.com, and www.phytobites.com.
Safe Harbor Notice
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The company undertakes no obligation to update any forward-looking statements.
Attachment
Contact: For further investor and media information, contact: CBD Unlimited, Inc. Todd Davis Chairman & CEO Todd@www.cbdunlimited.com 480-595-6900
